“Innovation in Radio-Oncology” Tel Aviv 1-3 March, 2017.
FOREWORD
This 3-day ESO course is dedicated to clinical, technical and biological innovations in the management of cancer with emphasis on radiation oncology. Hot topics such as single and hypo-fractionated RT, stereotactic brain and body RT, focal RT, particle RT, radiobiology of hypo-fractionation, SBRT and particle RT, the scientific basis of immunotherapy, combination of RT and immunotherapy and targeted therapies, prediction of response and complications, will be discussed. In addition, local Israeli high-tech achievements and innovations in basic and applied cancer research will be presented.
LEARNING OBJECTIVES
Update the knowledge in radiobiology, hypofractionated, stereotactic brain and body RT, focal RT, particle RT, the scientific basis of immunotherapy and combined RT – immunotherapy and targeted therapies.
Become aware of innovative strategies in radiation oncology and combined modality
therapy of cancer
Learn how to incorporate the innovative strategies in daily practice
CHAIRS AND COORDINATORS
F.A. Calvo, Hospital General Universitario Gregorio Maranon, Madrid, ES
J. Bernier, Genolier Swiss Medical Network, Genolier, CH
A. […]
AROME ESO Meeting Skopje 21.10. – 22.10.2016
Basic science behind oncology
1. Signalization session
Basic physiology of normal somatic cell – Yoseph Yarden
Basic physiology of cancer cell – Aleksandar Dimovski
Angiogenesis – Annete Larsen
Proliferative signaling – Yoseph Yarden
2. Immunology session
Basic immunology of normal somatic cell – Dejan Trajkovski
Immunology in cancer – Rodney Rosalia
RECIST vs IRRC – Lee Schwartzberg, Memphis
The immune check points in cancer – lecturer pending
Tumor vaccines – lecturer pending
Antineoplastone therapy – Milan Risteski
Clinical aspects of immune check point inhibitors – lecturer pending
3. Metabolism of the cancer cell session
Basic metabolism of normal somatic cell – Joseph Gligorov
Metabolism of cancer cell – lecturer pending
Apoptosis – Gvido Kroemer
Steriod receptor signaling in cancer cells – Joseph Gligorov
Metabolomics of cancer cells – Angelo Di Leo
PET imaging, prognosis, prediction and treatment efficacy evaluation – Khaldoun Kerrou, Adriano Duati, Emilija Janjevic
RECIST vs PERCIST – Khaldoun Kerrou
